Recap: Ocugen Q3 Earnings
Portfolio Pulse from Benzinga Insights
Ocugen (NASDAQ:OCGN) reported its Q3 earnings, beating estimated earnings by 14.29% with an EPS of $-0.06 versus an estimate of $-0.07. However, revenue was down $0 from the same period last year. Last quarter, the company missed on EPS by $0.03, which was followed by an 8.96% drop in the share price the next day.
November 09, 2023 | 11:20 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Ocugen's Q3 earnings beat estimates, but revenue was flat compared to last year. Last quarter's miss on EPS led to a significant drop in share price.
While Ocugen beat earnings estimates, the lack of revenue growth could be a concern for investors. Additionally, the significant drop in share price following last quarter's earnings miss may make investors cautious.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100